Work

A Phase II Trial of 90Y-Ibritumomab Tiuxetan-Based Reduced Intensity Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation for Relapsed CD20+ B-Cell Non-Hodgkins Lymphoma (NHL).

Year: 2006

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.316.316

Authors: Ajay K. Gopal, Joseph G. Rajendran, John M. Pagel, Katherine A. Guthrie, David G. Maloney, Frederick R. Appelbaum, Brenda M. Sandmaier, Rainer F. Storb, Oliver W. Press

Institutions: University of Washington, Fred Hutch Cancer Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2556970058

FWCI: 2.605

Cites:

Cited by: 16

Related to: 10